Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Jan 07, 2025

Standard Glass Lining IPO - Should You Subscribe? Read Geojit's Analysis

Standard Glass Lining IPO - Should You Subscribe? Read Geojit's Analysis
Standard Glass Lining Technology launched its Rs 419.05 crore IPO on January 06, for a fixed price band of Rs 133-140 per share. (Source: Company)

Standard Glass Lining Technology Ltd.'s Rs 419.05 crore IPO comprises of a fresh issue of shares worth up to Rs 219 crore and an offer-for-sale of 1.43 crore shares aggregating up to Rs 200.05 crore.

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Geojit Report

Standard Glass Lining Technology Ltd. launched its initial public offering on January 06 and the offer closes for subscription on Jan. 08. A specialized engineering equipment manufacturer for the pharmaceutical and chemical sectors in India has fixed the price band in the range of Rs 133-140 per share.

The Rs 419.05 crore IPO comprises of a fresh issue of shares worth up to Rs 219 crore and an offer-for-sale of 1.43 crore shares aggregating up to Rs 200.05 crore. The minimum order lot for bidding is 107 and in its multiples thereafter.

Purpose of IPO

Proceeds from fresh issue will fund capital expenditure, repay borrowings, invest in subsidiary S2 Engineering, Funding inorganic growth and cover general corporate purposes.

At the upper price band of Rs 140, Standard Glass Lining Technology is available at a P/E of 38.5x (on FY25 Annualised), which appears fairly priced compared to peers.

The growing demand for glass-lined equipment in pharmaceuticals and chemicals offers significant growth potential. Standard Glass Lining Technology's healthy margins, consistent revenue growth robust growth outlook, a diverse product portfolio with a focus on customization, and inorganic growth plans support a "Subscribe" rating for the stock on a medium to long term basis.

Key Risks

  • Depends on limited number of suppliers for key raw materials like stainless steel, chemicals and polytetrafluoroethylene powder etc.

  • Revenue depends heavily on pharmaceutical and chemical sectors.

  • Operates in a competitive market with established players.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search